Literature DB >> 19995475

Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect.

J Horacek1, M Brunovsky, T Novak, B Tislerova, T Palenicek, V Bubenikova-Valesova, F Spaniel, J Koprivova, P Mohr, M Balikova, C Hoschl.   

Abstract

BACKGROUND: Theta cordance is a novel quantitative electroencephalography (QEEG) measure that correlates with cerebral perfusion. A series of clinical studies has demonstrated that the prefrontal theta cordance value decreases after 1 week of treatment in responders to antidepressants and that this effect precedes clinical improvement. Ketamine, a non-competitive antagonist of N-methyl-D-aspartate (NMDA) receptors, has a unique rapid antidepressant effect but its influence on theta cordance is unknown.
METHOD: In a double-blind, cross-over, placebo-controlled experiment we studied the acute effect of ketamine (0.54 mg/kg within 30 min) on theta cordance in a group of 20 healthy volunteers.
RESULTS: Ketamine infusion induced a decrease in prefrontal theta cordance and an increase in the central region theta cordance after 10 and 30 min. The change in prefrontal theta cordance correlated with ketamine and norketamine blood levels after 10 min of ketamine infusion.
CONCLUSIONS: Our data indicate that ketamine infusion immediately induces changes similar to those that monoamineric-based antidepressants induce gradually. The reduction in theta cordance could be a marker and a predictor of the fast-acting antidepressant effect of ketamine, a hypothesis that could be tested in depressive patients treated with ketamine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995475     DOI: 10.1017/S0033291709991619

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  10 in total

Review 1.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

Review 2.  Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments.

Authors:  Andrew F Leuchter; Aimee M Hunter; David E Krantz; Ian A Cook
Journal:  Ann N Y Acad Sci       Date:  2015-03-23       Impact factor: 5.691

3.  Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.

Authors:  Carlos A Zarate; Nancy Brutsche; Gonzalo Laje; David A Luckenbaugh; Swarajya L Vattem Venkata; Anuradha Ramamoorthy; Ruin Moaddel; Irving W Wainer
Journal:  Biol Psychiatry       Date:  2012-04-18       Impact factor: 13.382

4.  Effects of Ketamine and Midazolam on Simultaneous EEG/fMRI Data During Working Memory Processes.

Authors:  Anna E M Forsyth; Rebecca McMillan; Juergen Dukart; Jörg F Hipp; Suresh D Muthukumaraswamy
Journal:  Brain Topogr       Date:  2021-10-13       Impact factor: 3.020

5.  A randomized controlled trial of intranasal ketamine in major depressive disorder.

Authors:  Kyle A B Lapidus; Cara F Levitch; Andrew M Perez; Jess W Brallier; Michael K Parides; Laili Soleimani; Adriana Feder; Dan V Iosifescu; Dennis S Charney; James W Murrough
Journal:  Biol Psychiatry       Date:  2014-04-03       Impact factor: 13.382

6.  On the danger of detecting network states in white noise.

Authors:  Jaroslav Hlinka; Michal Hadrava
Journal:  Front Comput Neurosci       Date:  2015-02-12       Impact factor: 2.380

7.  Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects.

Authors:  G Sanacora; M A Smith; S Pathak; H-L Su; P H Boeijinga; D J McCarthy; M C Quirk
Journal:  Mol Psychiatry       Date:  2013-10-15       Impact factor: 15.992

Review 8.  Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model.

Authors:  Moritz Haaf; Gregor Leicht; Stjepan Curic; Christoph Mulert
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

9.  Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Katherine Beck; Guy Hindley; Faith Borgan; Cedric Ginestet; Robert McCutcheon; Stefan Brugger; Naomi Driesen; Mohini Ranganathan; Deepak Cyril D'Souza; Matthew Taylor; John H Krystal; Oliver D Howes
Journal:  JAMA Netw Open       Date:  2020-05-01

Review 10.  Brain oscillations in bipolar disorder and lithium-induced changes.

Authors:  Murat İlhan Atagün
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-07       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.